Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vitro Susceptibility and Synergistic Effect of Bismuth Against Helicobacter pylori

25 Oct 2024

Abstract excerpt

Background/objectives: Bismuth is commonly used in Helicobacter pylori (H. pylori) eradication therapy. However, few studies have examined the in vitro susceptibility of H. pylori to bismuth. Moreover, the exact mechanism of action of bismuth on H. pylori remains unclear. The aim of this study was to identify the anti-bacterial effect of bismuth as well as to evaluate potential synergistic effects between bismuth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastroesophageal reflux and treatments
Share to Helicobacter pylori-related gastroenterology studies
Share to Veterinary medicine and infectious diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39596699
DOI: 10.3390/antibiotics13111004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

In Vitro Susceptibility and Synergistic Effect of Bismuth Against Helicobacter pyloriPMID 39596699Read ↗

Integrative proteomic and metabolomic analyses reveal the mechanism by which bismuth enables Helicobacter pylori eradicationSemantic proximity Read ↗

Weizmannia coagulans BC99 modulate gut microbiota after Helicobacter pylori eradication: A randomized double-blind placebo-controlled trialSemantic proximity Read ↗

Optimizing the Routine Use of Clinical Guidelines by Addition of Supplements (Probiotics and/or Bismuth) to <em>Helicobacter pylori</em> Eradication Protocols in a Clarithromycin Resistant and Tetracycline/Bismuth Naive Area: A Real-World Data Retrospective Analys of 402 Cases (2016-24) in a Single Gastroenterology UnitSemantic proximity Read ↗

Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitorsSemantic proximity Read ↗

Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin.Semantic proximity Read ↗

Attempts to enhance the eradication rate of Helicobacter pylori infection.Semantic proximity Read ↗

Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori InfectionSemantic proximity Read ↗

Genetic and phenotype changes following in vitro interactions between Helicobacter pylori strains.Semantic proximity Read ↗

A pharmacometric grey zone reconciles high metronidazole resistance rates with bismuth quadruple therapy efficacy in <i>Helicobacter pylori</i>Semantic proximity Read ↗

Antibacterial effect of kaempferol and (−)-epicatechin on Helicobacter pyloriSemantic proximity Read ↗

Effect of glycine on Helicobacter pylori in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.